Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colitis, Ulcerative | 69 | 2023 | 1912 | 10.620 |
Why?
|
Crohn Disease | 66 | 2023 | 2303 | 9.520 |
Why?
|
Colitis, Microscopic | 20 | 2024 | 77 | 8.860 |
Why?
|
Inflammatory Bowel Diseases | 51 | 2023 | 2425 | 6.280 |
Why?
|
Colitis, Collagenous | 10 | 2024 | 26 | 4.380 |
Why?
|
Colitis, Lymphocytic | 11 | 2024 | 25 | 4.130 |
Why?
|
Contraceptives, Oral | 7 | 2022 | 564 | 2.850 |
Why?
|
Sweden | 32 | 2023 | 1345 | 2.140 |
Why?
|
Gastrointestinal Agents | 10 | 2020 | 494 | 1.390 |
Why?
|
Diverticulum | 2 | 2020 | 136 | 1.240 |
Why?
|
Colorectal Neoplasms | 15 | 2023 | 6773 | 1.190 |
Why?
|
Prospective Studies | 71 | 2023 | 53288 | 1.180 |
Why?
|
Celiac Disease | 5 | 2023 | 785 | 1.150 |
Why?
|
Risk Factors | 78 | 2023 | 72290 | 1.150 |
Why?
|
Sick Leave | 4 | 2020 | 110 | 1.130 |
Why?
|
Estrogen Replacement Therapy | 4 | 2018 | 1203 | 1.100 |
Why?
|
Biological Therapy | 7 | 2021 | 138 | 1.020 |
Why?
|
Incidence | 39 | 2023 | 20947 | 0.990 |
Why?
|
Reproductive History | 3 | 2018 | 209 | 0.990 |
Why?
|
Budesonide | 3 | 2021 | 154 | 0.850 |
Why?
|
Intra-Abdominal Fat | 2 | 2018 | 591 | 0.850 |
Why?
|
Tuberculosis, Gastrointestinal | 2 | 2019 | 20 | 0.840 |
Why?
|
Proportional Hazards Models | 25 | 2022 | 12354 | 0.830 |
Why?
|
Tooth Loss | 1 | 2023 | 197 | 0.810 |
Why?
|
Registries | 17 | 2021 | 8089 | 0.800 |
Why?
|
Gastroenteritis | 2 | 2021 | 245 | 0.800 |
Why?
|
Colitis | 2 | 2020 | 1170 | 0.800 |
Why?
|
Diet | 8 | 2023 | 7939 | 0.780 |
Why?
|
Glutens | 2 | 2021 | 230 | 0.730 |
Why?
|
Periodontal Diseases | 1 | 2023 | 449 | 0.710 |
Why?
|
Humans | 178 | 2024 | 744343 | 0.700 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2022 | 238 | 0.690 |
Why?
|
Adult | 102 | 2023 | 214055 | 0.680 |
Why?
|
Middle Aged | 92 | 2023 | 213383 | 0.670 |
Why?
|
Colectomy | 4 | 2019 | 683 | 0.650 |
Why?
|
Case-Control Studies | 25 | 2023 | 21746 | 0.640 |
Why?
|
Proton Pump Inhibitors | 4 | 2020 | 526 | 0.630 |
Why?
|
Female | 118 | 2023 | 380194 | 0.620 |
Why?
|
Follow-Up Studies | 33 | 2023 | 39050 | 0.620 |
Why?
|
Diphosphonates | 2 | 2013 | 623 | 0.620 |
Why?
|
Proctitis | 1 | 2017 | 40 | 0.620 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2022 | 548 | 0.600 |
Why?
|
Bismuth | 2 | 2018 | 29 | 0.570 |
Why?
|
Iron, Dietary | 1 | 2017 | 141 | 0.560 |
Why?
|
Disease Progression | 8 | 2019 | 13284 | 0.550 |
Why?
|
Prevalence | 13 | 2022 | 15226 | 0.540 |
Why?
|
Salicylates | 2 | 2018 | 126 | 0.540 |
Why?
|
Clostridium Infections | 3 | 2018 | 548 | 0.540 |
Why?
|
Colonic Diseases | 1 | 2017 | 202 | 0.540 |
Why?
|
Heme | 1 | 2017 | 307 | 0.520 |
Why?
|
Colonoscopy | 9 | 2023 | 1367 | 0.520 |
Why?
|
Vegetables | 2 | 2020 | 1182 | 0.520 |
Why?
|
Alcohol Drinking | 3 | 2022 | 3966 | 0.510 |
Why?
|
Androgens | 1 | 2022 | 1281 | 0.500 |
Why?
|
Obesity | 7 | 2021 | 12745 | 0.500 |
Why?
|
Feeding Behavior | 4 | 2022 | 3188 | 0.500 |
Why?
|
Feces | 8 | 2021 | 1401 | 0.500 |
Why?
|
Aged | 59 | 2023 | 163280 | 0.490 |
Why?
|
Abdominal Pain | 3 | 2019 | 1063 | 0.480 |
Why?
|
GTP-Binding Proteins | 1 | 2018 | 970 | 0.470 |
Why?
|
Acetaminophen | 1 | 2018 | 545 | 0.470 |
Why?
|
Health Resources | 1 | 2020 | 911 | 0.470 |
Why?
|
Genetic Predisposition to Disease | 7 | 2022 | 17446 | 0.460 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2020 | 2282 | 0.450 |
Why?
|
Smoking | 9 | 2022 | 8987 | 0.450 |
Why?
|
Testosterone | 3 | 2022 | 2420 | 0.440 |
Why?
|
Diet, Mediterranean | 1 | 2020 | 700 | 0.440 |
Why?
|
Colonic Polyps | 3 | 2023 | 542 | 0.440 |
Why?
|
Tumor Necrosis Factor-alpha | 8 | 2020 | 4420 | 0.430 |
Why?
|
Young Adult | 36 | 2023 | 56430 | 0.430 |
Why?
|
Male | 86 | 2023 | 350118 | 0.430 |
Why?
|
Organometallic Compounds | 2 | 2018 | 665 | 0.420 |
Why?
|
Bacterial Infections | 1 | 2021 | 1401 | 0.420 |
Why?
|
Weight Gain | 2 | 2020 | 2292 | 0.410 |
Why?
|
Vitamin B 12 | 1 | 2015 | 527 | 0.400 |
Why?
|
Cohort Studies | 32 | 2023 | 40561 | 0.400 |
Why?
|
Microsatellite Instability | 1 | 2015 | 684 | 0.400 |
Why?
|
Menopause | 2 | 2018 | 1626 | 0.400 |
Why?
|
Risk Assessment | 24 | 2021 | 23338 | 0.400 |
Why?
|
Digestive System Surgical Procedures | 2 | 2016 | 576 | 0.400 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2021 | 3255 | 0.400 |
Why?
|
Immunosuppressive Agents | 4 | 2021 | 4149 | 0.390 |
Why?
|
Body Mass Index | 8 | 2018 | 12720 | 0.390 |
Why?
|
Health Surveys | 8 | 2018 | 4037 | 0.380 |
Why?
|
Polymorphism, Single Nucleotide | 10 | 2023 | 15519 | 0.380 |
Why?
|
Adenoma | 4 | 2023 | 2174 | 0.370 |
Why?
|
Age of Onset | 7 | 2020 | 3271 | 0.360 |
Why?
|
Postmenopause | 3 | 2017 | 2461 | 0.350 |
Why?
|
Multivariate Analysis | 15 | 2018 | 12245 | 0.340 |
Why?
|
Patient Compliance | 1 | 2020 | 2684 | 0.340 |
Why?
|
Adolescent | 32 | 2023 | 85781 | 0.330 |
Why?
|
ABO Blood-Group System | 1 | 2011 | 367 | 0.330 |
Why?
|
Biopsy | 13 | 2024 | 6756 | 0.320 |
Why?
|
Nurses | 7 | 2021 | 2461 | 0.320 |
Why?
|
Health Care Costs | 2 | 2023 | 3209 | 0.310 |
Why?
|
Pensions | 2 | 2019 | 15 | 0.300 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2021 | 2214 | 0.300 |
Why?
|
Life Style | 3 | 2017 | 3835 | 0.300 |
Why?
|
Risk | 6 | 2023 | 9687 | 0.300 |
Why?
|
Colon | 3 | 2020 | 1772 | 0.290 |
Why?
|
Adiposity | 1 | 2017 | 1807 | 0.290 |
Why?
|
Chronic Disease | 4 | 2022 | 9146 | 0.290 |
Why?
|
Dietary Fiber | 3 | 2023 | 760 | 0.280 |
Why?
|
Anti-Inflammatory Agents | 2 | 2016 | 1790 | 0.280 |
Why?
|
Severity of Illness Index | 9 | 2021 | 15540 | 0.270 |
Why?
|
Absenteeism | 2 | 2020 | 250 | 0.270 |
Why?
|
Prognosis | 14 | 2021 | 29063 | 0.260 |
Why?
|
Irritable Bowel Syndrome | 2 | 2021 | 445 | 0.260 |
Why?
|
Logistic Models | 9 | 2018 | 13408 | 0.250 |
Why?
|
Age Factors | 7 | 2021 | 18370 | 0.250 |
Why?
|
Aged, 80 and over | 20 | 2021 | 57776 | 0.250 |
Why?
|
Diabetes Mellitus | 2 | 2015 | 5751 | 0.250 |
Why?
|
Estradiol | 2 | 2022 | 2020 | 0.250 |
Why?
|
Hospitalization | 9 | 2021 | 10262 | 0.250 |
Why?
|
Quality of Life | 4 | 2021 | 12804 | 0.240 |
Why?
|
Liver Neoplasms | 4 | 2021 | 4253 | 0.240 |
Why?
|
Siblings | 3 | 2023 | 854 | 0.230 |
Why?
|
Population Surveillance | 4 | 2020 | 2616 | 0.230 |
Why?
|
Odds Ratio | 7 | 2021 | 9849 | 0.230 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2023 | 3336 | 0.230 |
Why?
|
Hepatitis B, Chronic | 2 | 2019 | 393 | 0.230 |
Why?
|
Hip Fractures | 1 | 2012 | 955 | 0.230 |
Why?
|
Motor Activity | 1 | 2013 | 2714 | 0.230 |
Why?
|
Surgical Procedures, Operative | 1 | 2015 | 1876 | 0.220 |
Why?
|
United States | 24 | 2020 | 69872 | 0.220 |
Why?
|
Massachusetts | 5 | 2018 | 8663 | 0.210 |
Why?
|
Time Factors | 14 | 2021 | 40075 | 0.210 |
Why?
|
Hypertension | 1 | 2022 | 8480 | 0.200 |
Why?
|
Histamine H2 Antagonists | 2 | 2020 | 165 | 0.200 |
Why?
|
Diarrhea | 4 | 2021 | 1348 | 0.200 |
Why?
|
Sigmoidoscopy | 2 | 2019 | 156 | 0.190 |
Why?
|
Exercise | 1 | 2017 | 5615 | 0.190 |
Why?
|
C-Reactive Protein | 4 | 2016 | 3778 | 0.190 |
Why?
|
Aspirin | 3 | 2020 | 3282 | 0.190 |
Why?
|
Manitoba | 1 | 2020 | 23 | 0.190 |
Why?
|
Diet Surveys | 3 | 2020 | 1173 | 0.180 |
Why?
|
Intestine, Large | 1 | 2019 | 71 | 0.170 |
Why?
|
Second-Look Surgery | 1 | 2019 | 29 | 0.170 |
Why?
|
Work | 1 | 2020 | 191 | 0.170 |
Why?
|
Appendectomy | 2 | 2022 | 401 | 0.170 |
Why?
|
Cecum | 1 | 2019 | 237 | 0.160 |
Why?
|
Adenomatous Polyps | 1 | 2019 | 107 | 0.160 |
Why?
|
Comorbidity | 7 | 2021 | 10388 | 0.160 |
Why?
|
Ruminococcus | 1 | 2017 | 12 | 0.160 |
Why?
|
Retrospective Studies | 20 | 2021 | 77449 | 0.160 |
Why?
|
Antidiarrheals | 1 | 2018 | 45 | 0.160 |
Why?
|
Fatty Liver | 1 | 2024 | 727 | 0.160 |
Why?
|
Gonadal Steroid Hormones | 1 | 2022 | 712 | 0.150 |
Why?
|
Unemployment | 1 | 2019 | 214 | 0.150 |
Why?
|
Dinoprostone | 1 | 2020 | 600 | 0.150 |
Why?
|
Dietary Fats | 2 | 2017 | 2017 | 0.150 |
Why?
|
Anti-Bacterial Agents | 5 | 2022 | 7181 | 0.150 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 2018 | 99 | 0.150 |
Why?
|
Mesalamine | 1 | 2018 | 136 | 0.150 |
Why?
|
Parkinson Disease | 2 | 2021 | 2775 | 0.150 |
Why?
|
Phenotype | 3 | 2022 | 16365 | 0.150 |
Why?
|
Fruit | 2 | 2020 | 1142 | 0.150 |
Why?
|
Drug Monitoring | 2 | 2020 | 956 | 0.140 |
Why?
|
Fluorocarbons | 1 | 2021 | 452 | 0.140 |
Why?
|
Microsatellite Repeats | 2 | 2016 | 802 | 0.140 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2022 | 924 | 0.140 |
Why?
|
Natural Language Processing | 1 | 2024 | 1041 | 0.130 |
Why?
|
Fatigue | 2 | 2020 | 1531 | 0.130 |
Why?
|
Quantitative Trait Loci | 1 | 2023 | 2019 | 0.130 |
Why?
|
Appendicitis | 1 | 2022 | 645 | 0.130 |
Why?
|
Defecation | 1 | 2017 | 188 | 0.130 |
Why?
|
Rosacea | 1 | 2015 | 49 | 0.130 |
Why?
|
Eosinophilic Esophagitis | 1 | 2018 | 168 | 0.130 |
Why?
|
Patient Care Management | 1 | 2018 | 306 | 0.130 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 1518 | 0.130 |
Why?
|
Tetracycline | 1 | 2015 | 214 | 0.130 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 15165 | 0.130 |
Why?
|
Anticarcinogenic Agents | 1 | 2017 | 253 | 0.130 |
Why?
|
Laxatives | 1 | 2015 | 87 | 0.130 |
Why?
|
Cause of Death | 3 | 2020 | 3584 | 0.130 |
Why?
|
Ostomy | 1 | 2014 | 27 | 0.130 |
Why?
|
Longitudinal Studies | 4 | 2020 | 13989 | 0.130 |
Why?
|
Anus Diseases | 1 | 2014 | 59 | 0.120 |
Why?
|
Remission Induction | 2 | 2019 | 2386 | 0.120 |
Why?
|
Canada | 1 | 2020 | 2065 | 0.120 |
Why?
|
Treatment Outcome | 15 | 2020 | 63114 | 0.120 |
Why?
|
Genetic Loci | 2 | 2021 | 2575 | 0.120 |
Why?
|
Fecal Incontinence | 1 | 2017 | 239 | 0.120 |
Why?
|
Immunocompromised Host | 1 | 2019 | 847 | 0.120 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2017 | 868 | 0.120 |
Why?
|
Disability Evaluation | 2 | 2018 | 1827 | 0.120 |
Why?
|
Cross-Sectional Studies | 6 | 2021 | 25043 | 0.110 |
Why?
|
Ileum | 1 | 2016 | 565 | 0.110 |
Why?
|
Endoscopy, Digestive System | 1 | 2016 | 345 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1125 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2018 | 11725 | 0.110 |
Why?
|
Methotrexate | 1 | 2019 | 1727 | 0.110 |
Why?
|
Radiography, Thoracic | 1 | 2019 | 1265 | 0.110 |
Why?
|
Beverages | 1 | 2018 | 820 | 0.110 |
Why?
|
Steroids | 1 | 2018 | 930 | 0.110 |
Why?
|
Adrenal Cortex Hormones | 3 | 2016 | 1855 | 0.110 |
Why?
|
Peptic Ulcer | 1 | 2014 | 223 | 0.110 |
Why?
|
Disabled Persons | 2 | 2019 | 1212 | 0.110 |
Why?
|
Myocardial Ischemia | 1 | 2023 | 2148 | 0.110 |
Why?
|
Iran | 1 | 2015 | 708 | 0.100 |
Why?
|
Antigen Presentation | 1 | 1997 | 1284 | 0.100 |
Why?
|
Intestinal Mucosa | 2 | 2020 | 3036 | 0.100 |
Why?
|
Constriction, Pathologic | 1 | 2015 | 1107 | 0.100 |
Why?
|
Biological Products | 1 | 2021 | 860 | 0.100 |
Why?
|
Government Programs | 1 | 2014 | 275 | 0.100 |
Why?
|
Fever | 1 | 2019 | 1616 | 0.100 |
Why?
|
Zinc | 1 | 2015 | 684 | 0.100 |
Why?
|
Recurrence | 4 | 2016 | 8340 | 0.100 |
Why?
|
Sleep | 3 | 2016 | 4623 | 0.100 |
Why?
|
Genome-Wide Association Study | 6 | 2024 | 12261 | 0.100 |
Why?
|
Hepatitis C, Chronic | 1 | 2019 | 1031 | 0.100 |
Why?
|
Constipation | 1 | 2015 | 546 | 0.100 |
Why?
|
Food Hypersensitivity | 1 | 2018 | 622 | 0.090 |
Why?
|
Vitamin D | 2 | 2016 | 3223 | 0.090 |
Why?
|
Pedigree | 1 | 2018 | 4644 | 0.090 |
Why?
|
Fetus | 1 | 1997 | 1880 | 0.090 |
Why?
|
Child | 13 | 2023 | 77709 | 0.090 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 13695 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2864 | 0.090 |
Why?
|
Fatty Acids | 1 | 2017 | 1809 | 0.090 |
Why?
|
Geography | 1 | 2012 | 669 | 0.090 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2013 | 484 | 0.090 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1170 | 0.080 |
Why?
|
Women's Health | 1 | 2019 | 2034 | 0.080 |
Why?
|
Mucous Membrane | 2 | 2023 | 673 | 0.080 |
Why?
|
Gene Expression Regulation | 2 | 2023 | 12072 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2018 | 2107 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2019 | 2266 | 0.080 |
Why?
|
Affect | 1 | 2016 | 1476 | 0.080 |
Why?
|
Sex Characteristics | 1 | 2019 | 2585 | 0.080 |
Why?
|
Smoking Cessation | 2 | 2018 | 2071 | 0.080 |
Why?
|
Gene Frequency | 1 | 2015 | 3588 | 0.080 |
Why?
|
Breast Feeding | 2 | 2014 | 1338 | 0.080 |
Why?
|
Child, Preschool | 6 | 2022 | 41006 | 0.080 |
Why?
|
Stroke | 2 | 2023 | 9981 | 0.080 |
Why?
|
Liver Cirrhosis | 3 | 2024 | 1863 | 0.080 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3022 | 0.080 |
Why?
|
Vitamins | 1 | 2016 | 1622 | 0.080 |
Why?
|
Diagnosis, Differential | 3 | 2019 | 12959 | 0.070 |
Why?
|
Hyperglycemia | 1 | 2016 | 1373 | 0.070 |
Why?
|
Iron | 1 | 2015 | 1774 | 0.070 |
Why?
|
Antirheumatic Agents | 1 | 2016 | 1339 | 0.070 |
Why?
|
Forecasting | 1 | 2016 | 2951 | 0.070 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2024 | 1475 | 0.070 |
Why?
|
Metagenome | 2 | 2021 | 418 | 0.070 |
Why?
|
Genes, Tumor Suppressor | 1 | 2010 | 1097 | 0.070 |
Why?
|
Quality of Health Care | 1 | 2021 | 4371 | 0.070 |
Why?
|
Interleukin-6 | 1 | 2016 | 3200 | 0.070 |
Why?
|
Heart Failure | 2 | 2023 | 10900 | 0.070 |
Why?
|
Infant, Newborn | 5 | 2019 | 25625 | 0.070 |
Why?
|
Length of Stay | 2 | 2016 | 6309 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20129 | 0.070 |
Why?
|
Critical Illness | 2 | 2016 | 2670 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3086 | 0.060 |
Why?
|
Carcinoma | 1 | 2017 | 2375 | 0.060 |
Why?
|
Gene Expression | 1 | 2018 | 7799 | 0.060 |
Why?
|
Birth Weight | 1 | 2013 | 2069 | 0.060 |
Why?
|
Cost of Illness | 1 | 2014 | 1859 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3674 | 0.060 |
Why?
|
Gene Silencing | 1 | 2010 | 1538 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2017 | 3265 | 0.060 |
Why?
|
Infant, Premature | 1 | 2013 | 2044 | 0.060 |
Why?
|
Propensity Score | 2 | 2021 | 1781 | 0.060 |
Why?
|
Lung | 2 | 2019 | 9856 | 0.060 |
Why?
|
Echinococcosis | 1 | 2002 | 30 | 0.060 |
Why?
|
Macrophages | 1 | 1997 | 5655 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2017 | 4043 | 0.050 |
Why?
|
Genotype | 4 | 2018 | 12951 | 0.050 |
Why?
|
Osteoporosis | 1 | 2012 | 1580 | 0.050 |
Why?
|
Insulin Resistance | 1 | 2016 | 3864 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7279 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2011 | 1343 | 0.050 |
Why?
|
Residence Characteristics | 1 | 2012 | 2050 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6364 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2015 | 3679 | 0.050 |
Why?
|
Peptide Elongation Factors | 1 | 2001 | 62 | 0.050 |
Why?
|
DNA Methylation | 2 | 2016 | 4286 | 0.050 |
Why?
|
Morbidity | 2 | 2018 | 1769 | 0.050 |
Why?
|
Self Report | 3 | 2020 | 3558 | 0.050 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2020 | 103 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2014 | 4234 | 0.050 |
Why?
|
Treatment Failure | 2 | 2016 | 2618 | 0.040 |
Why?
|
Boston | 3 | 2018 | 9313 | 0.040 |
Why?
|
Cognition | 1 | 2017 | 6770 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2020 | 12026 | 0.040 |
Why?
|
Pacific Ocean | 1 | 2019 | 16 | 0.040 |
Why?
|
Sex Factors | 3 | 2018 | 10397 | 0.040 |
Why?
|
Insurance, Disability | 1 | 2018 | 26 | 0.040 |
Why?
|
Blood | 1 | 2021 | 598 | 0.040 |
Why?
|
Thrombospondins | 1 | 2019 | 197 | 0.040 |
Why?
|
Regression Analysis | 2 | 2021 | 6459 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2005 | 1836 | 0.040 |
Why?
|
Immunologic Factors | 2 | 2019 | 1580 | 0.040 |
Why?
|
HLA Antigens | 1 | 2024 | 1381 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 407 | 0.040 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2001 | 502 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2022 | 783 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13102 | 0.040 |
Why?
|
Enterocytes | 1 | 2019 | 225 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19905 | 0.040 |
Why?
|
New Zealand | 1 | 2018 | 355 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3752 | 0.040 |
Why?
|
Proteomics | 2 | 2021 | 3638 | 0.040 |
Why?
|
Linear Models | 2 | 2018 | 5952 | 0.040 |
Why?
|
Animals | 4 | 2018 | 168757 | 0.040 |
Why?
|
Asia | 1 | 2019 | 610 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6489 | 0.040 |
Why?
|
Liver | 3 | 2021 | 7474 | 0.040 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 1997 | 318 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2019 | 10943 | 0.040 |
Why?
|
Depression | 2 | 2016 | 7766 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2013 | 4838 | 0.040 |
Why?
|
Hybridomas | 1 | 1997 | 452 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3920 | 0.040 |
Why?
|
Butyrates | 1 | 2017 | 163 | 0.040 |
Why?
|
Mice, Inbred C3H | 1 | 1997 | 964 | 0.030 |
Why?
|
Ileitis | 1 | 2016 | 44 | 0.030 |
Why?
|
Infant | 4 | 2019 | 35136 | 0.030 |
Why?
|
Capsules | 1 | 2016 | 196 | 0.030 |
Why?
|
Weight Loss | 2 | 2019 | 2622 | 0.030 |
Why?
|
Freezing | 1 | 2016 | 303 | 0.030 |
Why?
|
Prostaglandins | 1 | 2017 | 405 | 0.030 |
Why?
|
Antibodies, Monoclonal | 3 | 2019 | 9274 | 0.030 |
Why?
|
Survival Rate | 3 | 2020 | 12788 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 2010 | 3143 | 0.030 |
Why?
|
Netherlands | 1 | 2020 | 2170 | 0.030 |
Why?
|
Hormones | 1 | 2019 | 889 | 0.030 |
Why?
|
Australia | 1 | 2018 | 1170 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 1997 | 1827 | 0.030 |
Why?
|
North America | 1 | 2018 | 1249 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 8428 | 0.030 |
Why?
|
Metagenomics | 1 | 2018 | 428 | 0.030 |
Why?
|
Cytokines | 2 | 2021 | 7322 | 0.030 |
Why?
|
Gastritis | 1 | 2016 | 196 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2021 | 1359 | 0.030 |
Why?
|
Medical History Taking | 1 | 2018 | 783 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2010 | 4262 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1997 | 1155 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15295 | 0.030 |
Why?
|
SEER Program | 1 | 2019 | 1508 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2015 | 528 | 0.030 |
Why?
|
Survival | 1 | 2013 | 163 | 0.030 |
Why?
|
Metabolome | 1 | 2020 | 895 | 0.030 |
Why?
|
Species Specificity | 1 | 2017 | 2478 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2019 | 899 | 0.030 |
Why?
|
Brain Diseases | 1 | 2002 | 1563 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 35421 | 0.030 |
Why?
|
Survival Analysis | 2 | 2016 | 10252 | 0.030 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2015 | 482 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15076 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2297 | 0.030 |
Why?
|
Retirement | 1 | 2014 | 215 | 0.030 |
Why?
|
Metabolomics | 1 | 2021 | 1484 | 0.030 |
Why?
|
Genome, Bacterial | 1 | 2017 | 760 | 0.030 |
Why?
|
GTP Phosphohydrolases | 1 | 2016 | 509 | 0.030 |
Why?
|
Integrins | 1 | 2017 | 846 | 0.030 |
Why?
|
Plasma | 1 | 2016 | 575 | 0.030 |
Why?
|
Seafood | 1 | 2015 | 384 | 0.030 |
Why?
|
Biostatistics | 1 | 2014 | 162 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2015 | 592 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2902 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2016 | 5867 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2018 | 814 | 0.030 |
Why?
|
Immunoglobulin E | 1 | 2018 | 1463 | 0.030 |
Why?
|
Genetic Markers | 1 | 2018 | 2634 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2018 | 3508 | 0.030 |
Why?
|
Europe | 1 | 2018 | 3339 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2018 | 2373 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2016 | 1880 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2016 | 1850 | 0.020 |
Why?
|
Algorithms | 2 | 2024 | 13881 | 0.020 |
Why?
|
Efficiency | 1 | 2014 | 462 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2019 | 1889 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1462 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2019 | 10180 | 0.020 |
Why?
|
Helicobacter pylori | 1 | 2014 | 382 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 1344 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3527 | 0.020 |
Why?
|
Women | 1 | 2012 | 230 | 0.020 |
Why?
|
Phylogeny | 1 | 2017 | 2803 | 0.020 |
Why?
|
Adiponectin | 1 | 2016 | 1100 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 1997 | 1678 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2001 | 2752 | 0.020 |
Why?
|
HIV Infections | 1 | 2016 | 16718 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2005 | 3712 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 21683 | 0.020 |
Why?
|
Collagen | 1 | 2018 | 2689 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2015 | 1182 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4933 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2017 | 1901 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1831 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2016 | 1035 | 0.020 |
Why?
|
Glucose | 1 | 2001 | 4397 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 3913 | 0.020 |
Why?
|
Tobacco Smoke Pollution | 1 | 2014 | 816 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 1997 | 6386 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1692 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2016 | 1403 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2001 | 3703 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 905 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1889 | 0.020 |
Why?
|
Employment | 1 | 2014 | 1132 | 0.020 |
Why?
|
Memory | 1 | 2017 | 2174 | 0.020 |
Why?
|
Schools | 1 | 2015 | 1433 | 0.020 |
Why?
|
Bacteria | 1 | 2018 | 2114 | 0.020 |
Why?
|
Attention | 1 | 2017 | 2400 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9438 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2017 | 3086 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2703 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5078 | 0.020 |
Why?
|
Eating | 1 | 2013 | 1536 | 0.020 |
Why?
|
Pediatrics | 1 | 2021 | 3475 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2043 | 0.020 |
Why?
|
Genetic Testing | 1 | 2018 | 3444 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3597 | 0.020 |
Why?
|
Alleles | 1 | 2016 | 6933 | 0.020 |
Why?
|
Radiography | 1 | 2016 | 7023 | 0.020 |
Why?
|
Inpatients | 1 | 2016 | 2518 | 0.020 |
Why?
|
Health Status | 1 | 2017 | 4034 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2017 | 6993 | 0.020 |
Why?
|
Health Personnel | 1 | 2018 | 3218 | 0.020 |
Why?
|
Databases, Factual | 1 | 2019 | 7729 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2001 | 9648 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8324 | 0.010 |
Why?
|
Cell Line | 1 | 1997 | 15997 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 2538 | 0.010 |
Why?
|
Iraq | 1 | 2002 | 92 | 0.010 |
Why?
|
Hospitals | 1 | 2016 | 3952 | 0.010 |
Why?
|
Anxiety | 1 | 2016 | 4297 | 0.010 |
Why?
|
Rupture, Spontaneous | 1 | 2002 | 354 | 0.010 |
Why?
|
Blood Glucose | 1 | 2016 | 6256 | 0.010 |
Why?
|
Insulin | 1 | 2016 | 6580 | 0.010 |
Why?
|
Transcription Factors | 1 | 2001 | 12208 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9239 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 5987 | 0.010 |
Why?
|
Genomics | 1 | 2017 | 5720 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10638 | 0.010 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2001 | 144 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6234 | 0.010 |
Why?
|
Transcriptional Elongation Factors | 1 | 2001 | 166 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2016 | 7880 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 9959 | 0.010 |
Why?
|
Genome, Human | 1 | 2010 | 4420 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2001 | 1202 | 0.010 |
Why?
|
Protein Subunits | 1 | 2001 | 959 | 0.010 |
Why?
|
RNA Polymerase II | 1 | 2001 | 551 | 0.010 |
Why?
|
Fungal Proteins | 1 | 2001 | 912 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2001 | 2839 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2001 | 2256 | 0.010 |
Why?
|
Mammals | 1 | 2001 | 1143 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2001 | 4320 | 0.010 |
Why?
|
Mice | 2 | 2001 | 81183 | 0.010 |
Why?
|
Reoperation | 1 | 2002 | 4201 | 0.010 |
Why?
|
Caenorhabditis elegans | 1 | 2001 | 1419 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2001 | 1708 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 29786 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2001 | 6622 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2005 | 19229 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2001 | 13815 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2001 | 5097 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 2001 | 18111 | 0.000 |
Why?
|
Rats | 1 | 2001 | 24260 | 0.000 |
Why?
|
Signal Transduction | 1 | 2005 | 23403 | 0.000 |
Why?
|